An example of this scenario can be found in breast cancer, where TP53 mutations are present in only a quarter of cases [80], an increased ratio of ∆40p53:FLp53 has been identified in comparison to normal adjacent tissue [69], and this increased ratio was linked to worse disease-free survival [57,69]. The gene discussed is TP53; the disease is breast carcinoma.